Manufacturing

Articles

CellVax Therapeutics has selected Theragent, a new CDMO, to manufacture clinical trial material for a new Phase II prostate cancer immunotherapy drug candidate.

CellVax and Theragent Form Manufacturing Pact for Novel Cancer Immunotherapy Drug Candidate

The newly formed partnership between CSafe and BioLife will expand cold chain supply chain solutions for the cell and gene therapy market.

CSafe and BioLife Solutions Partnership Will Expand Supply Chain for Cell and Gene Therapies

AAPS Conference Highlights 2022

Cleo Bern Hartley is a pharma consultant, former pharma analyst, and research scientist.

Biopharma focuses on streamlining biomanufacturing and supply chain issues to drive uptake of cell and gene therapies.

Growth in Cell and  Gene Therapy Market

Julie Tilbury is a collection network liaison at Be The Match BioTherapies.

Document integrity is critical in the provision of raw materials for cell and gene therapy manufacturing.

Real-Time Post-Apheresis Documentation Decreases Errors

Matt Hewitt is executive director, Scientific Services Cell and Gene Therapy at Charles River.

For cell and gene therapies to reach their full potential, changes in manufacturing must be explored.

The Road to Personalized Medicine: Reimagining Drug Manufacturing 

Forecyte Bio and Cytiva will team up to accelerate the development and manufacturing of cell and gene therapies.


Forecyte Bio and Cytiva to Collaborate on Cell and Gene Therapy Manufacturing and Development

Izaskun Elorza, MD, is the senior medical director for cell and gene therapy at Parexel.

The clinical trial research environment has evolved because of specific solutions designed to overcome uncertainty.

The Evolution of Cellular Therapies in a New Clinical Research Environment

Pfizer and Touchlight have signed a patent license agreement for Pfizer to use Touchlight’s doggybone DNA (dbDNA) in the manufacture of mRNA vaccines, therapeutics, and gene therapies.

Pfizer and Touchlight Enter Patent License Agreement for Use of dbDNA

Finding specific solutions to overcome uncertainty has led to the evolution of a new clinical trial research environment.

Manufacturing, Cell Therapies